NUCB2 and myocardial infarction: Dai et al. [4] were the first to observe a significant reduction in nesfatin-1 levels in patients with myocardial infarction, and, during the last five years, a small number of studies has put the association between nesfatin-1 levels and CAD under the spotlight [5–8].